Published in Biol Psychiatry on September 01, 2004
Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry (2008) 1.58
A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neurosci Biobehav Rev (2009) 1.49
Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry Res (2012) 1.23
Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol (2010) 1.19
Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci (2012) 1.17
Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol Psychiatry (2007) 1.12
Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology (2010) 1.10
Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top Magn Reson Imaging (2008) 1.03
Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment. J Neurovirol (2009) 1.02
Lithium treatment effects on Myo-inositol in adolescents with bipolar depression. Biol Psychiatry (2006) 0.94
Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study. J Psychiatry Neurosci (2012) 0.93
Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update. Dialogues Clin Neurosci (2013) 0.90
Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study. Bipolar Disord (2008) 0.89
Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin Ther Targets (2014) 0.89
A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy. J Psychiatry Neurosci (2008) 0.88
Effect of divalproex on brain morphometry, chemistry, and function in youth at high-risk for bipolar disorder: a pilot study. J Child Adolesc Psychopharmacol (2009) 0.86
Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation. Psychiatry Res (2013) 0.84
Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. Neuropsychopharmacology (2012) 0.84
On blending practice and research: the search for commonalities in substance abuse treatment. Subst Abus (2006) 0.83
Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.83
Effects of lithium on cortical thickness and hippocampal subfield volumes in psychotic bipolar disorder. J Psychiatr Res (2014) 0.80
Neurometabolite effects of response to quetiapine and placebo in adolescents with bipolar depression. J Child Adolesc Psychopharmacol (2012) 0.79
Menstrual effects on mood symptoms in treated women with bipolar disorder. Bipolar Disord (2011) 0.79
Lithium's role in neural plasticity and its implications for mood disorders. Acta Psychiatr Scand (2013) 0.78
An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar Disorder. Clin Transl Sci (2015) 0.77
A review of MR spectroscopy studies of pediatric bipolar disorder. AJNR Am J Neuroradiol (2014) 0.77
Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges. Front Cell Neurosci (2017) 0.75
Neurochemical metabolites in the medial prefrontal cortex in bipolar disorder: A proton magnetic resonance spectroscopy study. Neural Regen Res (2012) 0.75
Biologic Commonalities between Mental Illness and Addiction. Prim psychiatry (2009) 0.75
Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study. J Clin Psychopharmacol (2016) 0.75
Main Effects of Diagnoses, Brain Regions, and their Interaction Effects for Cerebral Metabolites in Bipolar and Unipolar Depressive Disorders. Sci Rep (2016) 0.75
Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol (2006) 5.48
Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am J Psychiatry (2012) 3.38
Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry (2008) 3.28
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry (2006) 3.01
An alternative way to individualized medicine: psychological and physical traits of Sasang typology. J Altern Complement Med (2003) 2.70
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A (2003) 2.56
Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J Altern Complement Med (2010) 2.50
Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes (2006) 2.42
Consensus paper: pathological role of the cerebellum in autism. Cerebellum (2012) 2.32
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety (2012) 2.23
The developmental neurobiology of autism spectrum disorder. J Neurosci (2006) 2.21
Altitude, gun ownership, rural areas, and suicide. Am J Psychiatry (2010) 2.18
Brains on video games. Nat Rev Neurosci (2011) 2.12
Long-term seizure, cognitive, and psychiatric outcome following trans-middle temporal gyrus amygdalohippocampectomy and standard temporal lobectomy. J Neurosurg (2013) 2.04
The possible effect of altitude on regional variation in suicide rates. Med Hypotheses (2009) 1.99
Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry (2004) 1.89
Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol (2008) 1.87
Default mode network abnormalities in bipolar disorder and schizophrenia. Psychiatry Res (2010) 1.84
Acute air pollution exposure and risk of suicide completion. Am J Epidemiol (2015) 1.73
Trait and state aspects of harm avoidance and its implication for treatment in major depressive disorder, dysthymic disorder, and depressive personality disorder. Psychiatry Clin Neurosci (2004) 1.66
Attention deficit hyperactivity symptoms and internet addiction. Psychiatry Clin Neurosci (2004) 1.65
Frontal lobe gray matter density decreases in bipolar I disorder. Biol Psychiatry (2004) 1.65
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry (2002) 1.65
Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord (2006) 1.59
Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry (2008) 1.58
Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology (2007) 1.57
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry (2007) 1.54
Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study. Am J Geriatr Psychiatry (2009) 1.50
Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. J Autism Dev Disord (2012) 1.49
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology (2005) 1.47
Depression and Internet addiction in adolescents. Psychopathology (2007) 1.47
Longitudinal patterns of repetitive behavior in toddlers with autism. J Child Psychol Psychiatry (2014) 1.44
Yoga Asana sessions increase brain GABA levels: a pilot study. J Altern Complement Med (2007) 1.44
A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry (2005) 1.43
Intellect declines in healthy elderly subjects and cerebellum. Psychiatry Clin Neurosci (2005) 1.42
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. J Clin Psychiatry (2006) 1.42
Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology (2007) 1.41
Amygdala and hippocampus volumes in pediatric major depression. Biol Psychiatry (2005) 1.40
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry (2007) 1.40
Elevated gamma-aminobutyric acid levels in chronic schizophrenia. Biol Psychiatry (2010) 1.38
Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology (2009) 1.36
Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch Gen Psychiatry (2007) 1.36
Depression like characteristics of 5HTTLPR polymorphism and temperament in excessive internet users. J Affect Disord (2007) 1.34
Amygdalar volume and behavioral development in autism. Arch Gen Psychiatry (2006) 1.32
MR spectroscopic imaging: principles and recent advances. J Magn Reson Imaging (2012) 1.31
Brain volume findings in 6-month-old infants at high familial risk for autism. Am J Psychiatry (2012) 1.30
Decreased frontal white-matter integrity in abstinent methamphetamine abusers. Int J Neuropsychopharmacol (2006) 1.29
Brain activity and desire for Internet video game play. Compr Psychiatry (2011) 1.28
Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMA-simulated basis sets at 4 Tesla. NMR Biomed (2009) 1.26
Hippocampal volume, PTSD, and alcoholism in combat veterans. Am J Psychiatry (2006) 1.24
White matter microstructure and atypical visual orienting in 7-month-olds at risk for autism. Am J Psychiatry (2013) 1.23
Diminished rostral anterior cingulate activity in response to threat-related events in posttraumatic stress disorder. J Psychiatr Res (2007) 1.23
The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder. Compr Psychiatry (2008) 1.22
White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders. Compr Psychiatry (2002) 1.22
Gray and white matter brain chemistry in young children with autism. Arch Gen Psychiatry (2006) 1.21
Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging. NMR Biomed (2005) 1.20
Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biol Psychiatry (2005) 1.20
Abnormal T2 relaxation time in the cerebellar vermis of adults sexually abused in childhood: potential role of the vermis in stress-enhanced risk for drug abuse. Psychoneuroendocrinology (2001) 1.20
Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl) (2005) 1.19
Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep (2008) 1.18
Asymmetrically altered integrity of cingulum bundle in posttraumatic stress disorder. Neuropsychobiology (2007) 1.18
Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int J Neuropsychopharmacol (2005) 1.18
Bupropion sustained release treatment decreases craving for video games and cue-induced brain activity in patients with Internet video game addiction. Exp Clin Psychopharmacol (2010) 1.18
Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann N Y Acad Sci (2010) 1.17
High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.16
Reliability and validity of the Korean version of the Temperament and Character Inventory. Compr Psychiatry (2002) 1.16
A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V. Bipolar Disord (2004) 1.15
Transcranial magnetic stimulation reduces pain in patients with major depression: a sham-controlled study. J Nerv Ment Dis (2007) 1.15
Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology (2005) 1.14
Gait unsteadiness and fall risk in two affective disorders: a preliminary study. BMC Psychiatry (2004) 1.14
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. Sleep (2003) 1.14
T2 relaxation time abnormalities in bipolar disorder and schizophrenia. Magn Reson Med (2010) 1.13
Full syndrome and subthreshold attention-deficit/hyperactivity disorder in a Korean community sample: comorbidity and temperament findings. Eur Child Adolesc Psychiatry (2009) 1.12
Disrupted white matter tract integrity of anterior cingulate in trauma survivors. Neuroreport (2005) 1.12
Smaller frontal lobe white matter volumes in depressed adolescents. Biol Psychiatry (2002) 1.11
Creatine abnormalities in schizophrenia and bipolar disorder. Psychiatry Res (2009) 1.11
Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res (2003) 1.11
Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder. Psychiatry Res (2009) 1.11
Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. Am J Psychiatry (2004) 1.10